Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Nichi-Iko Takes Over Marketing Authorization for Etanercept Biosimilar from Kyowa
Nichi-Iko Pharmaceutical on February 29 took over the marketing authorization for Kyowa Pharmaceutical Industry’s Enbrel (etanercept) biosimilar.Kyowa obtained approval for the product in March last year, and it was launched by Nichi-Iko last November. Kyowa initially planned to transfer the…
To read the full story
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





